Skip to content

A trial of crystalloid versus colloid fluid solutions for the resuscitation of patients with severe injuries

Comparison of crystalloid-blood resuscitation with crystalloid-colloid-blood resuscitation in severe trauma patients: a randomised double-blind trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42061860
Enrollment
140
Registered
2009-07-24
Start date
2007-12-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe blunt or penetrating trauma Injury, Occupational Diseases, Poisoning Severe trauma

Interventions

1. Intravenous fluid administration to haemodynamic and physiological endpoints as required, 0.9% saline 2. HES 130/0.4 in saline (Voluven®) Time taken to achieve haemodynamic goals is recorded. Durat
follow-up for 30 days from enrolment or death.

Sponsors

University of Cape Town (South Africa)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients suffering severe trauma requiring at least 3 litres of estimated resuscitation fluid admitted to Groote Shuur Hospital Trauma Unit 2. Penetrating or blunt trauma (separately randomised) 3. Aged greater than 18 years and less than 60 years, either sex

Exclusion criteria

Exclusion criteria: 1. Fluid overload pulmonary oedema 2. Known allergy to hydroxyethyl starch 3. Known pre-existing renal failure with oliguria including anuria, severe intracranial bleeding, severe hypernatremia or severe hyperchloremia on admission 4. Severe head injury from which they are unlikely to recover 5. Severe crush injury 6. Unrecordable blood pressure unresponsive to 2 l fluid loading 7. Clinically obvious cardiac tamponade 8. Neurogenic shock (high spinal) 9. Known acquired immune deficiency syndrome (AIDS) or AIDS related complex 10. Patients receiving dialysis treatment 11. Patients admitted greater than 6 hours following injury 12. Patients who have already received non-study colloids 13. Patients taking part in another clinical trial at the same time 14. Patients refusing consent

Design outcomes

Primary

MeasureTime frame
1. Volumes of fluids required to meet resuscitation goals over the first 24 hours from study entry 2. Time (days) until recovery of bowel function as determined by tolerance of oral of parenteral feeding

Secondary

MeasureTime frame
1. Days free of gastrointestinal dysfunction during first 30 days 2. Median and maximal sequential organ failure assessment (SOFA) score 3. Length of stay in Intensive Care Unit (LOS in ICU) 4. Fluid volumes used during initial surgical procedures 5. Time to initial achievement of resuscitation target values 6. Intra-abdominal pressure following resuscitation 7. Time to first passage of stool

Countries

South Africa

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026